Abstract: | Atropine-induced decrease in the concentration of acetylcholine (ACh) in the brain can be diminished by pretreating the animals with a large dose of choline72,73. The injected choline might act by improving the supply of substrate for the synthesis of ACh, or by competing with atropine for presynaptic muscarinic receptors and thus decreasing the release of ACh. Since, under in vitro conditions, changes in the release of ACh are reflected by changes in its synthesis, experiments have been performed on slices of rat caudate nuclei to check whether an increase in the extracellular concentration of choline causes a decrease in the atropine-induced stimulation of ACh synthesis. The rate of [14C]ACh synthesis from [14C]glucose was faster in the presence of 530 μM than 30 μM choline, and 5 μM atropine stimulated the synthesis of [14C]ACh more at 530 μM than at 30 μM choline in the medium. These observations substantiate the view that the administration of choline in vivo acts by supporting the synthesis of ACh, rather than by inhibiting its release. In subsequent experiments on rats in vivo, an attempt has been made to influence the ACh-depleting action of atropine by pretreatment with a large dose of glucose as a distant precursor of acetyl-CoA, the second substrate for the synthesis of ACh. The administration of atropine (25 mg/kg) diminished the content of ACh in the caudate nuclei by 48%; if the injection of atropine followed after an injection of glucose (20.2 mmol/kg), the content of ACh was diminished by only 25%. It appears likely that glucose acted by improving the availability of acetyl-CoA for the synthesis of ACh and that the supply of either precursor of ACh (i.e. choline and acetyl-CoA) may become rate-limiting when the demands on the synthesis of ACh in the brain are increased. |